Last reviewed · How we verify

NCT02972996

Blueberry Consumption and Type 2 Diabetes

Completed NA Results posted Last updated 19 April 2022
What this trial tests

NA trial testing Blueberry in Type2 Diabetes in 55 participants. Completed in 21 June 2018.

Timeline
19 January 2017
Primary endpoint
21 June 2018
21 June 2018

Quick facts

Lead sponsorAlbany Research Institute, Inc.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment55
Start date19 January 2017
Primary completion21 June 2018
Estimated completion21 June 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Albany Research Institute, Inc.

Who can join

Adults 45 to 75, male only, with Type2 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Blood Pressure Primary · 8 weeks

Systolic blood pressure and diastolic blood pressure.

Systolic blood pressure
GroupValue95% CI
Blueberry125.6± 2.5
Placebo126.0± 2.5
Diastolic blood pressure
GroupValue95% CI
Blueberry74.6± 1.0
Placebo75.1± 1.0
Hemoglobin A1C Secondary · 8 weeks

Hemoglobin A1C is a surrogate marker of glycemic control over the preceding 2-3 months.

GroupValue95% CI
Blueberry7.1± 0.1
Placebo7.5± 0.2

Sponsor's own description

Lifestyle strategies that include dietary modification, such as consumption of a plant-based diet, are well recognized in disease prevention and may improve type 2 diabetes. Various components of a plant-based diet may contribute to its beneficial health effects, but there has been keen interest in the possibility that plant polyphenols may have a role. Blueberries are dietary sources of polyphenols, specifically anthocyanins. To date there are few human clinical trials evaluating the beneficial health effects of blueberries in populations with type 2 diabetes. The objective of the study is to determine if freeze-dried blueberries compared to a blueberry placebo will improve cardiometabolic parameters in men with type 2 diabetes.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Dietary Anthocyanins and Insulin Resistance: When Food Becomes a Medicine.
    Belwal T, Nabavi SF, Nabavi SM, Habtemariam S. · · 2017 · cited 94× · PMID 29023424 · DOI 10.3390/nu9101111
  2. Effect of Blueberry Consumption on Cardiometabolic Health Parameters in Men with Type 2 Diabetes: An 8-Week, Double-Blind, Randomized, Placebo-Controlled Trial.
    Stote KS, Wilson MM, Hallenbeck D, Thomas K, et al · · 2020 · cited 49× · PMID 32337475 · DOI 10.1093/cdn/nzaa030
  3. The Dash Diet Pattern and Blood Pressure Changes in US Veterans With Type 2 Diabetes – a Post-hoc Analysis of the Blueberry Consumption and Type 2 Diabetes Study
    · 2022

Verify or expand the search:

Other trials of Blueberry

Trials testing the same drug.

Other recruiting trials for Type2 Diabetes

Currently open trials in the same condition.

Other Albany Research Institute, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02972996.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing